Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Overview
Analysis
Risks
Rating
Chart
Analysts
Street
Sentiment
Earnings
Headlines
CMPS
COMPASS Pathways Plc
$8.03
1159
Overview
Analysis
Risks
Rating
Chart
Analysts
Street
Sentiment
Earnings
Headlines
CMPS Stock Rating Review
Login to display COMPASS Pathways Plc (CMPS) recommendation from the last 90 days from financial news and social media.
CMPS Total Score
Strengths
Upgraded on attractively valued
Outperform the market
Chart
6.66
8.25
9.79
9.09
CMPS Risk Level
This Indicator assigning CMPS risk levels based on factors such as volatility, sector strength, trading volume, investor confidence and market outlook.
Risk Volatility
CMPS has High Risk Level
Click here to check what is your level of risk
CMPS Analysts Opinion
CMPS overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Below analyst estimate
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Future
Future
Outperform the market
CMPS Analysts opinion is positive and also has improved from the past 3 months
CMPS Street Consensus
Analysts perspectives on the stock desirability, trend direction, and growth potential.
Opinion
Score
Score
CMPS Street view is extremely ish and have positive views on the near-term outlook
CMPS Performance Sentiment
events present
events present
Bullish
Neutral
Bearish
Very Bearish
CMPS Earnings
The TTM reflects 12-month period, providing review of CMPS financial performance.
CMPS Financial Health
The company financial health has shown minor improvement, but significant issues remain. Moderate market demand and partially effective business strategies have led to slight profitability gains, but cost management and operational efficiency still need considerable improvement.
Financial Score
AXSM
Axsome Therapeutics
86.53
+0.64%
AMGN
Amgen
334.85
+0.16%
Explore our CMPS Stock insights
- In-Depth Market Analysis and Trends
- Expert Insights on Market Dynamics
- Tailored CMPS Stock Strategies
- Effective Risk Management
FIND US ON
Receive our CMPS Daily Alerts
Access the exclusive insights that over 10,000+ subscribers value. Stay ahead in the stock market! Submit your email for daily alerts.
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses.
Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
